Key facts
- This page summarizes John M. Evans's Form 4 filing for Beam Therapeutics Inc. (BEAM).
- 10 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 01 Jul 2026, 16:05.
John M. Evans - 29 Jun 2026 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)
- Reporting relationship
- CEO, Director
- Issuer ticker
- BEAM
- Reported as of
- 29 Jun 2026
- Net transaction value
- -$1,745,037
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2026, 16:05:11 UTC
- Prior SEC filing
- 06 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Christine Bellon, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John M. Evans filed Form 4 for Beam Therapeutics Inc. (BEAM) on 01 Jul 2026.
Change
- Previous filing in this sequence was filed on 06 Apr 2026.
- Current net transaction value: -$1,745,037.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001786304
Primary reporting owner
Evans John M.
- Relationship
- CEO, Director
- Address
- C/O BEAM THERAPEUTICS INC.,, 238 MAIN STREET, CAMBRIDGE
- Signature
- By: /s/ Christine Bellon, Attorney-in-fact
- Signature date
- 01 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BEAM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +18,663
- Change %
- +1.8%
- Price
- $0.6700*
- Shares after
- 1,065,868
- Date
- 29 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
BEAM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,337
- Change %
- +0.59%
- Price
- $1.03*
- Shares after
- 1,072,205
- Date
- 29 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
BEAM
transaction
Common Stock
Sale
- Transaction value
- $471,528
- Shares
- -13,421
- Change %
- -1.3%
- Price
- $35.13
- Shares after
- 1,058,784
- Date
- 29 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2
BEAM
transaction
Common Stock
Sale
- Transaction value
- $415,824
- Shares
- -11,579
- Change %
- -1.1%
- Price
- $35.91
- Shares after
- 1,047,205
- Date
- 29 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F3
BEAM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +25,000
- Change %
- +2.4%
- Price
- $1.03*
- Shares after
- 1,072,205
- Date
- 30 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
BEAM
transaction
Common Stock
Sale
- Transaction value
- $791,482
- Shares
- -23,100
- Change %
- -2.2%
- Price
- $34.26
- Shares after
- 1,049,105
- Date
- 30 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F4
BEAM
transaction
Common Stock
Sale
- Transaction value
- $66,203
- Shares
- -1,900
- Change %
- -0.18%
- Price
- $34.84
- Shares after
- 1,047,205
- Date
- 30 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F5
BEAM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 103,000
- Date
- 29 Jun 2026
- Ownership
- By John M. Evans, III 2018 Irrevocable Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BEAM
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -18,663
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 9
- Date
- 29 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,663
- Exercise price
- $0.6700
- Footnotes
- F1, F6
BEAM
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -6,337
- Change %
- -2.7%
- Price
- $0.000000*
- Shares after
- 230,804
- Date
- 29 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,337
- Exercise price
- $1.03
- Footnotes
- F1, F7
BEAM
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -25,000
- Change %
- -11%
- Price
- $0.000000*
- Shares after
- 205,804
- Date
- 30 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $1.03
- Footnotes
- F1, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 7 footnotes
Footnote F1
The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.55 to $35.50, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.60 to $36.18, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.80 to $34.71, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.83 to $34.85, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F6
On May 8, 2018, the Reporting Person was granted an option to purchase shares of common stock, which vested as to 99,396 shares upon the achievement of a certain development milestone related to base editing applications. On April 3, 2024, the board of directors of BEAM determined that this performance condition was achieved, resulting in the vesting of 99,336 shares.
Footnote F7
On July 13, 2018, the Reporting Person was granted an option to purchase 539,645 shares of common stock, which vested as to 25% of the underlying shares on January 8, 2019 and in 36 equal monthly installments thereafter.